European Review for Medical and Pharmacological Sciences, 23 (12), 5512-5521
July 1, 2026: Over 300 Depo-Provera Lawsuits Join Federal MDL as Settlement Talks Continue As of July 1, 2026, there are 5,830 lawsuits that are pending in the Depo-Provera MDL
A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from tirzepatide therapy, taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman
State pharmacy board actions: State boards have suspended or revoked pharmacy licenses for compounding violations, including inadequate sterility assurance, failure to perform required testing, and dispensing without valid prescriptions
Patients seeking faster weight loss sometimes ask whether stacking phenterminea decades-old sympathomimetic stimulantwith newer GLP-1 receptor agonists like Zepbound creates a more powerful effect
Metabolic syndrome update